Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000913133 | SCV001058271 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002502750 | SCV002805455 | likely benign | Donnai-Barrow syndrome | 2021-07-21 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000913133 | SCV005256556 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003950776 | SCV004761986 | likely benign | LRP2-related disorder | 2021-08-31 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |